Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>Reprimo</i> as a Potential Biomarker for Early Detection in Gastric Cancer

30 Sept 2008

Abstract excerpt

PURPOSE: Gastric cancer is a curable disease if diagnosed at early stage. However, most cases are diagnosed at advanced stage because of the lack of screening programs. Therefore, the identification of plasma biomarkers for early detection is necessary. EXPERIMENTAL DESIGN: To search for these biomarkers, we evaluated the DNA methylation patterns of 24 genes by Methylation-specific PCR in primary tissues from 32...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Epigenetics and DNA Methylation
Share to Gastric Cancer Management and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18829507
DOI: 10.1158/1078-0432.ccr-07-4522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>Reprimo</i> as a Potential Biomarker for Early Detection in Gastric CancerPMID 18829507Read ↗

Aberrant Methylation of <i>RASGRF1</i> Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric CancerSemantic proximity Read ↗

SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancerSemantic proximity Read ↗

Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric CancerSemantic proximity Read ↗

Aberrant Methylation of<i>APC, MGMT, RASSF2A</i>, and<i>Wif-1</i>Genes in Plasma as a Biomarker for Early Detection of Colorectal CancerSemantic proximity Read ↗

Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution arraySemantic proximity Read ↗

Aberrant Gene Methylation Is a Biomarker for the Detection of Cancer Cells in Peritoneal Wash Samples from Advanced Gastric Cancer PatientsSemantic proximity Read ↗

Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Aberrant promoter methylation of <i>PPP1R3C</i> and <i>EFHD1</i> in plasma of colorectal cancer patientsSemantic proximity Read ↗

Methylation of <i>APC, TIMP3</i>, and <i>TERT</i>: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformationSemantic proximity Read ↗

Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes.Semantic proximity Read ↗

DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesisSemantic proximity Read ↗

Role of RECK methylation in gastric cancer and its clinical significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.